Patents by Inventor Bret Huff

Bret Huff has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Excitatory amino acid receptor antagonists
    Patent number: 5675008
    Abstract: This invention provides novel decahydroisoquinoline compounds which are useful as excitatory amino acid receptor antagonists and in the treatment of neurological disorders. This invention also provides synthetic methods for preparing decahydroisoquinolines, as well as, novel intermediates in the synthesis thereof.
    Type: Grant
    Filed: June 1, 1995
    Date of Patent: October 7, 1997
    Assignee: Eli Lilly and Company
    Inventors: Carl F. Bertsch, Bret Huff, Michael J. Martinelli, Paul L. Ornstein
  • Process for preparing isoquinoline compounds
    Patent number: 5648492
    Abstract: This invention provides novel decahydroisoquinoline compounds which are useful as excitatory amino acid receptor antagonists and in the treatment of neurological disorders. This invention also provides synthetic methods for preparing decahydroisoquinolines, as well as, novel intermediates in the synthesis thereof.
    Type: Grant
    Filed: June 1, 1995
    Date of Patent: July 15, 1997
    Assignee: Eli Lilly and Company
    Inventors: M. Brian Arnold, Carl F. Bertsch, Marvin M. Hansen, Allen R. Harkness, Bret Huff, Michael J. Martinelli, Paul L. Ornstein
  • Process of preparing isoquinoline compounds
    Patent number: 5637712
    Abstract: This invention provides novel decahydroisoquinoline compounds which are useful as excitatory amino acid receptor antagonists and in the treatment of neurological disorders. This invention also provides synthetic methods for preparing decahydroisoquinolines, as well as, novel intermediates in the synthesis thereof.
    Type: Grant
    Filed: November 21, 1994
    Date of Patent: June 10, 1997
    Assignee: Eli Lilly and Company
    Inventors: Carl F. Bertsch, Bret Huff, Michael J. Martinelli
  • Isoquinolinyl-carboxylic acid receptor antagonists compounds
    Patent number: 5606062
    Abstract: This invention provides novel decahydroisoquinoline compounds which are useful as excitatory amino acid receptor antagonists and in the treatment of neurological disorders. This invention also provides synthetic methods for preparing decahydroisoquinolines, as well as, novel intermediates in the synthesis thereof.
    Type: Grant
    Filed: June 1, 1995
    Date of Patent: February 25, 1997
    Assignee: Eli Lilly and Company
    Inventor: Bret Huff
  • Excitatory amino acid receptor antagonists
    Patent number: 5284957
    Abstract: This invention provides compounds which are useful in the preparation of AMPA receptor antagonists.
    Type: Grant
    Filed: September 3, 1992
    Date of Patent: February 8, 1994
    Assignee: Eli Lilly and Company
    Inventor: Bret Huff